Search research articles
Contact Us
Filters
Showing results (661-670 of 718) with videos related to
Page
of 72
Sort By:
ESMO Gastrointestinal Oncology
|
April 6, 2026
Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases
M Barsch, I Godbole, P Metzger, et al.
The Annals of Thoracic Surgery
|
March 1, 2014
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer
Eric L Grogan, Stephen A Deppen, Karla V Ballman, et al.
Science Translational Medicine
|
February 14, 2024
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization
Jiajia Chen, Daniel J Laverty, Surabhi Talele, et al.
Neuro-Oncology
|
March 31, 2025
The impact of therapeutic radiation on drug distribution across the blood-brain barrier in normal mouse brain and orthotopic GBM tumors
Wenjuan Zhang, Michael P Grams, Rajneet K Oberoi, et al.
AJNR. American Journal of Neuroradiology
|
January 9, 2025
Deep learning MRI models for the differential diagnosis of tumefactive demyelination versus <i>IDH</i>-wildtype glioblastoma
Gian Marco Conte, Mana Moassefi, Paul A Decker, et al.
Cancer Genetics
|
March 2, 2011
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity
Robert B Jenkins, Margaret R Wrensch, Derek Johnson, et al.
Experimental Neurology
|
August 7, 2007
Loss and spontaneous recovery of forelimb evoked potentials in both the adult rat cuneate nucleus and somatosensory cortex following contusive cervical spinal cord injury
Stephen M Onifer, Christine D Nunn, Julie A Decker, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma
Jenny L Pokorny, David Calligaris, Shiv K Gupta, et al.
Molecular Cancer Therapeutics
|
November 19, 2024
Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628
Darwin A Garcia, Sneha Rathi, Margaret A Connors, et al.
Page
of 72
Search research articles
Search
Showing results (661-670 of 718) with videos related to
Sort By:
Page
of 72
ESMO Gastrointestinal Oncology
|
April 6, 2026
Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases
M Barsch, I Godbole, P Metzger, et al.
The Annals of Thoracic Surgery
|
March 1, 2014
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer
Eric L Grogan, Stephen A Deppen, Karla V Ballman, et al.
Science Translational Medicine
|
February 14, 2024
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization
Jiajia Chen, Daniel J Laverty, Surabhi Talele, et al.
Neuro-Oncology
|
March 31, 2025
The impact of therapeutic radiation on drug distribution across the blood-brain barrier in normal mouse brain and orthotopic GBM tumors
Wenjuan Zhang, Michael P Grams, Rajneet K Oberoi, et al.
AJNR. American Journal of Neuroradiology
|
January 9, 2025
Deep learning MRI models for the differential diagnosis of tumefactive demyelination versus <i>IDH</i>-wildtype glioblastoma
Gian Marco Conte, Mana Moassefi, Paul A Decker, et al.
Cancer Genetics
|
March 2, 2011
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity
Robert B Jenkins, Margaret R Wrensch, Derek Johnson, et al.
Experimental Neurology
|
August 7, 2007
Loss and spontaneous recovery of forelimb evoked potentials in both the adult rat cuneate nucleus and somatosensory cortex following contusive cervical spinal cord injury
Stephen M Onifer, Christine D Nunn, Julie A Decker, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma
Jenny L Pokorny, David Calligaris, Shiv K Gupta, et al.
Molecular Cancer Therapeutics
|
November 19, 2024
Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628
Darwin A Garcia, Sneha Rathi, Margaret A Connors, et al.
Page
of 72